(Large-cap) stocks provide the same relative safety and advantages that large-cap drug stocks provide. Despite the economic environment, people do need their drugs. Large-cap drug stocks are seen as a safe haven with relatively inelastic demand.
I think the earnings thing was the big thing. And even before that figure was announced, the earnings for the year had been downgraded from above $5 a share for the past two quarters.
In order for the small caps to really come back into favor, I think some of the valuations of these drug stocks will have to either remain where they are or come down a bit.
People have come to expect that. We did see some exciting drugs, we did get to see some new things. But it might have fallen short of past meetings.
The patents that are expiring make up a significant portion of their results. They're not going to be one of the top growth stories -- probably only single-digit (percentage-wise) in 2000 and 2001.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.